StockData
Dare Bioscience, Inc. logo

Dare Bioscience, Inc. (DARE) stock

DARENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 5/30
$0.43−0.16 (-26.57%)

Close on Nov 17, 2026Market cap $6.56MP/E –Yield –

Dare Bioscience r&d expenses

Research and development expenses are spending on new products and technology.

Dare Bioscience's R&D Expenses for the twelve months ending Jun 30, 2026 was $2.70M, down 72.3% year over year. For fiscal 2025 it was $5.52M, down 61.4% from the year before. Over ten years it grew -14.3% a year on average. The highest annual figure on record is $30.62M in fiscal 2021.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$5.52M-61.4%
FY2024Dec 31, 2024$14.31M-33.6%
FY2023Dec 31, 2023$21.54M-28.3%
FY2022Dec 31, 2022$30.04M-1.9%
FY2021Dec 31, 2021$30.62M+47.4%
FY2020Dec 31, 2020$20.77M+143.0%
FY2019Dec 31, 2019$8.55M+33.2%
FY2018Dec 31, 2018$6.41M+551.3%
FY2017Dec 31, 2017$984.75K+1255.2%
FY2016Dec 31, 2016$72.67K-99.7%
FY2015Dec 31, 2015$25.95M+120.4%
FY2014Dec 31, 2014$11.77M+21.4%
FY2013Dec 31, 2013$9.70M-38.6%
FY2012Dec 31, 2012$15.81M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$241.97K-83.1%
Q1 FY2026Mar 31, 2026$660.46K-71.3%
Q4 FY2025Dec 31, 2025$622.04K-81.4%
Q3 FY2025Sep 30, 2025$1.18M-56.2%
Q2 FY2025Jun 30, 2025$1.43M-71.0%
Q1 FY2025Mar 31, 2025$2.30M-31.5%
Q4 FY2024Dec 31, 2024$3.34M-12.2%
Q3 FY2024Sep 30, 2024$2.68M-59.8%
Q2 FY2024Jun 30, 2024$4.93M-18.4%
Q1 FY2024Mar 31, 2024$3.35M-33.2%
Q4 FY2023Dec 31, 2023$3.80M-70.7%
Q3 FY2023Sep 30, 2023$6.67M+49.6%
Q2 FY2023Jun 30, 2023$6.04M-11.1%
Q1 FY2023Mar 31, 2023$5.02M-13.5%
Q4 FY2022Dec 31, 2022$12.98M+82.3%
Q3 FY2022Sep 30, 2022$4.46M-57.2%
Q2 FY2022Jun 30, 2022$6.80M-7.4%
Q1 FY2022Mar 31, 2022$5.81M+1.3%
Q4 FY2021Dec 31, 2021$7.12M+7.2%
Q3 FY2021Sep 30, 2021$10.43M+68.2%
Q2 FY2021Jun 30, 2021$7.34M+32.3%
Q1 FY2021Mar 31, 2021$5.73M+140.7%
Q4 FY2020Dec 31, 2020$6.64M+179.6%
Q3 FY2020Sep 30, 2020$6.20M+215.5%
Q2 FY2020Jun 30, 2020$5.55M+120.8%
Q1 FY2020Mar 31, 2020$2.38M+40.5%
Q4 FY2019Dec 31, 2019$2.37M+42.7%
Q3 FY2019Sep 30, 2019$1.97M+35.9%
Q2 FY2019Jun 30, 2019$2.51M+13.3%
Q1 FY2019Mar 31, 2019$1.69M+55.8%
Q4 FY2018Dec 31, 2018$1.66M+147.3%
Q3 FY2018Sep 30, 2018$1.45M+415.2%
Q2 FY2018Jun 30, 2018$2.22M+61914.0%
Q1 FY2018Mar 31, 2018$1.09M+3808.8%
Q4 FY2017Dec 31, 2017$672.58K-78.9%
Q3 FY2017Sep 30, 2017$280.79K-96.0%
Q2 FY2017Jun 30, 2017$3.58K–
Q1 FY2017Mar 31, 2017$27.80K–
Q4 FY2016Dec 31, 2016$3.18M–
Q3 FY2016Sep 30, 2016$7.09M–

More Dare Bioscience figures

See a number that looks wrong?